Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease

International Journal of Cardiology

Volumn 117, Issue 1, 2007, Pages 59-63

  Ribeiro, Antonio Luiz Pinho ^a,b   Giménez, Luis Eduardo Díaz ^c   Hernández, Ciria Carolina Quintero ^c   de Carvalho, Antonio Carlos Campos ^c   Teixeira, Mauro Martins ^b   Guedes, Valesca Costa ^a,b   Barros, Márcio Vinícius Lins ^a,d   Lombardi, Federico ^e   da Costa Rocha, Manoel Otávio ^a  

^a Uveitis Section   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Ecoar Medicina Diagnóstica ^*  (Brazil)

^e Ospedale San Paolo   (Italy)

Author keywords

Autonomic nervous system; Chagas disease; Heart rate variability; Neurotransmitter receptor autoantibodies

Indexed keywords

AUTOANTIBODY; MUSCARINIC M2 RECEPTOR;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CHAGAS DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART RATE VARIABILITY; HEART VENTRICLE WALL MOTION; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OPTICAL DENSITY; PRIORITY JOURNAL; VAGUS NERVE; VAGUS NERVE STIMULATION;

ADULT; AUTOANTIBODIES; AUTONOMIC NERVOUS SYSTEM DISEASES; BIOLOGICAL MARKERS; CHAGAS DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; RECEPTORS, MUSCARINIC; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947256115     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.04.053     Document Type: Article

References (23)

1. Chagas disease. Disease Watch 2003. TDR | Nature Reviews Microbiology Available at: http://www.who.int/tdr/dw/chagas2003.htm. Acessed April 10, 2004.
2. Rocha M.O., Ribeiro A.L., and Teixeira M.M. Clinical management of chronic Chagas cardiomyopathy. Front Biosci 8 (2003) E44-E54
3. Sterin-Borda L., and Borda E. Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia. Ann N Y Acad Sci 917 (2000) 273-280
4. Oliveira S.F., Pedrosa R.C., Nascimento J.H., Campos de Carvalho A.C., and Masuda M.O. Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation 96 (1997) 2031-2037
5. Goin J.C., Borda E.S., Auger S., Storino R., and Sterin-Borda L. Cardiac M(2) muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia. Heart 82 3 (Sep 1999) 273-278
6. Ribeiro A.L., Moraes R.S., Ribeiro J.P., et al. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 141 (2001) 260-265
7. Oliveira E., Ribeiro A.L.P., Silva F.A., Torres R.M., and Rocha M.O.C. The Valsalva maneuver in Chagas disease patients without cardiopathy. Int J Cardiol 82 (2002) 49-54
8. Ribeiro AL, Ferreira LM, Oliveira E, Cruzeiro PC, Torres RM, Rocha MO. Active orthostatic stress and respiratory sinus arrhythmia in patients with Chagas' disease with preserved left ventricular global systolic function. Arq Bras Cardiol. 2004 (Jul);83(1):40-4; 35-9.
9. Ribeiro A.L., Lombardi F., Sousa M.R., et al. Power-law behavior of heart rate variability in Chagas disease. Am J Cardiol 89 (2002) 414-418
10. Ribeiro A.L., Schmidt G., Sousa M.R., et al. Heart rate turbulence in Chagas disease. Pacing Clin Electrophysiol 26 1 Pt 2 (2003) 406-410
11. Ribeiro A.L., Lombardi F., Sousa M.R., and Rocha M.O. Vagal dysfunction in Chagas disease. Int J Cardiol 103 2 (2005) 225-226
12. Villar J.C., Leon H., and Morillo C.A. Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagas' disease. Int J Cardiol 93 2-3 (Feb 2004) 189-195
13. Junqueira Jr. L.F., and Soares J.D. Impaired autonomic control of heart interval changes to Valsalva manoeuvre in Chagas' disease without overt manifestation. Auton Neurosci 97 1 (Apr 18 2002) 59-67
14. Marin-Neto J.A., Bromberg-Marin G., Pazin-Filho A., Simoes M.V., and Maciel B.C. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease. Int J Cardiol 65 3 (Aug 1998) 261-269
15. Borda E.S., and Sterin Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. Int J Cardiol 54 (1996) 149-156
16. Freedman N.J., and Lefkowitz R.J. Anti-beta1-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Invest 113 (2004) 1379-1382
17. Fu M.L. Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy. Int J Cardiol 54 2 (May 1996) 127-135
18. Davila D.F., Santiago J.J., and Odreman W.A. Vagal dysfunction and the pathogenesis of chronic Chagas disease. Int J Cardiol 100 2 (Apr 20 2005) 337-339
19. Barros M.V., Ribeiro A.L., Machado F.S., et al. Doppler tissue imaging to assess systolic function in Chagas disease. Arq Bras Cardiol 80 (2003) 36-40
20. Task Force of the European Society of Cardiology and the North American Society of Cardiac Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 93 (1996) 1043-1065
21. Goin J.C., Borda E., Leiros C.P., Storino R., and Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Auton Nerv Syst 47 1-2 (Apr 1994) 45-52
22. Levin M.J., Levitus G., Kerner N., et al. Autoantibodies in Chagas' heart disease: possible markers of severe Chagas' heart complaint. Mem Inst Oswaldo Cruz 85 4 (Oct-Dec 1990) 539-543
23. Lombardi F. Clinical implications of present physiological understanding of HRV components. Card Electrophysiol Rev 6 (2002) 245-249